Back to News
Market Impact: 0.2

Chinese chip stocks: These are the best value plays

Source: Investing.com

Technology & InnovationCompany FundamentalsAnalyst InsightsMarket Technicals & FlowsEmerging MarketsInvestor Sentiment & Positioning
Chinese chip stocks: These are the best value plays

Nasdaq finished up more than 1.5% as tech rallied following Nvidia’s blockbuster earnings, while the article highlights China semiconductor “value” via several P/E- and ROE-screened names. Dmegc Magnetics (002056) is cited at 19.2x P/E with ~32.4% fair-value upside and ~2.9% positive free-cash-flow yield; Shenzhen Longsys Electronics (301308) at 15.7x P/E with ~21% upside amid a turnaround (ROE improving to ~19.9%). The piece is broadly constructive on select Chinese/HK chip stocks, but flags limited upside (Raytron ~-0.9%) and downside risk in ASM Pacific (~-14%) and “speculative” AV Concept (5.4x P/E but thin 8.6% gross margins).

Analysis

NVDA’s earnings strength matters less as a standalone print than as a signal that AI capex is still being funded aggressively, which keeps the global semiconductor complex bid. The spillover is uneven: U.S. GPU, networking, and power infrastructure names should keep capturing the highest-quality dollars, while China semis mostly get a sentiment lift unless they are tied to domestic substitution, memory, or packaging. That means the market may be overgeneralizing one winner’s momentum into a broader China-chip re-rating that the supply chain cannot fully support.

The risk in the Chinese names is not that they are expensive in absolute terms, but that low multiples can become value traps when growth normalizes faster than investors expect. The best-supported longs are the names with real free cash flow and visible ROE, while high-multiple turnarounds remain fragile if revenue momentum decelerates by even a modest amount. Near term, watch U.S.-China policy, RMB moves, and any evidence that inventory restocking is peaking; those are the most likely catalysts to compress the rerating in 1-3 months.

Contrarian view: the consensus is too eager to treat every semiconductor as an AI beneficiary. In reality, the China basket is a domestic-cycle and policy trade, not a pure AI trade, so upside is likely concentrated in a few self-sufficiency beneficiaries rather than the entire group. If AI spend stays U.S.-centric for the next 6-18 months, the relative winner should be NVDA and its ecosystem, not the broader China semi universe.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.20

Ticker Sentiment

NVDA0.70

Key Decisions for Investors

  • Long NVDA on pullbacks over the next 1-3 months; use a 5%-8% drawdown as entry and fade any gap-up exhaustion. Risk/reward is favorable as long as the post-earnings breakout holds; thesis fails if hyperscaler capex commentary rolls over next quarter.
  • Pair trade: long NVDA / short CHIP (or another China semiconductor basket) for 1-3 months. This isolates the gap between U.S. AI monetization and China domestic substitution. Cover if China policy stimulus or export-control relief creates a broad re-rating in mainland chip names.
  • Relative value: long 301308 (Shenzhen Longsys) vs short 0522 (ASM Pacific Technology) over 1-2 quarters. Favor the higher-growth, lower-multiple recovery with better operating leverage; short the expensive turnaround unless revenue re-accelerates and margin recovery becomes visible.
  • Selective watchlist entry: buy 002056 (Dmegc Magnetics) only on a 10%+ pullback, as a cash-generative China semiconductor value name. It is the cleanest way to express the domestic-cycle thesis; invalidated if free-cash-flow yield compresses without further ROE improvement.
  • Avoid initiating new longs in 688002 and 0522 at current multiples; they require flawless execution. If either misses revenue growth or gross margin expansion next print, expect multiple compression rather than support from sector sentiment.

More News

From AllMind Research

Browse all research